AU4841799A - Methods and pharmaceutical formulations for preventing and treating motion sickness - Google Patents

Methods and pharmaceutical formulations for preventing and treating motion sickness

Info

Publication number
AU4841799A
AU4841799A AU48417/99A AU4841799A AU4841799A AU 4841799 A AU4841799 A AU 4841799A AU 48417/99 A AU48417/99 A AU 48417/99A AU 4841799 A AU4841799 A AU 4841799A AU 4841799 A AU4841799 A AU 4841799A
Authority
AU
Australia
Prior art keywords
preventing
methods
pharmaceutical formulations
motion sickness
treating motion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48417/99A
Inventor
Vincent D. Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
MDRNA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDRNA Inc filed Critical MDRNA Inc
Publication of AU4841799A publication Critical patent/AU4841799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48417/99A 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness Abandoned AU4841799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9111498P 1998-06-29 1998-06-29
US60091114 1998-06-29
PCT/US1999/014657 WO2000000193A1 (en) 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness

Publications (1)

Publication Number Publication Date
AU4841799A true AU4841799A (en) 2000-01-17

Family

ID=22226169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48417/99A Abandoned AU4841799A (en) 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness

Country Status (2)

Country Link
AU (1) AU4841799A (en)
WO (1) WO2000000193A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US9138228B2 (en) 2004-08-11 2015-09-22 Emory University Vascular conduit device and system for implanting
US7846123B2 (en) 2007-04-24 2010-12-07 Emory University Conduit device and system for implanting a conduit device in a tissue wall
CA2824936A1 (en) 2011-01-28 2012-08-02 Apica Cardiovascular Limited Systems for sealing a tissue wall puncture
AU2012212215B2 (en) 2011-02-01 2015-07-30 Emory University Systems for implanting and using a conduit within a tissue wall
EP2948104B1 (en) 2013-01-25 2019-07-24 Apica Cardiovascular Limited Systems for percutaneous access, stabilization and closure of organs
EP2968717A4 (en) 2013-03-15 2017-02-22 Apk Advanced Medical Technologies, Inc. Devices, systems, and methods for implanting and using a connnector in a tissue wall
US10485909B2 (en) 2014-10-31 2019-11-26 Thoratec Corporation Apical connectors and instruments for use in a heart wall
CA3173515A1 (en) * 2020-04-16 2021-10-21 Steven C. Quay Compositions and methods to reduce the infectivity of a virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
WO2000000193A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
IL131201A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
SG79255A1 (en) Pharmaceutical formulations
IL127559A0 (en) Compounds and methods for providing pharmacologically active preparations and uses thereof
AU5565099A (en) Pharmaceutical compositions and methods for use
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
IL211081A0 (en) Methods and devices for providing prolonged drug therapy
AU3472799A (en) Dermatological formulations and methods
AU4841799A (en) Methods and pharmaceutical formulations for preventing and treating motion sickness
EP1075184A4 (en) Compositions and methods for active vaccination
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
HUP9902458A3 (en) Slow-release pharmaceutical formulations containing mizolastin
GB9818927D0 (en) Pharmaceutical formulation
EP0987942A4 (en) Pharmaceutical composition and methods for using it
EP1142589A4 (en) Medicinal preparations
IL136635A0 (en) Pharmaceutical formulations and processes for their preparation
GB9822333D0 (en) Pharmaceutical formulation
GB9817470D0 (en) Pharmaceutical formulation
IL137076A0 (en) Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi
GB9615710D0 (en) Pharmaceutical preparations for the treatment of sarcocystosis
ZA9811105B (en) Cosmetic and pharmaceutical composition
GB9802617D0 (en) Pharmaceutical formulation
HUP0001584A3 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
AU9173298A (en) Methods and compositions for medical imaging
GB9820837D0 (en) Pharmaceutical formulations
GB9825117D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase